ATIS is on the move! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move!

ATIS 0.1000

-47.4%

Apr 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jeff Jordan who wrote (2170)	9/27/2001 10:07:32 AM
From: Bruce Long	Read Replies (1) of 2205

Marshall and all, CardioGenesis Corporation Appoints Joseph R. Kletzel II to Board of Directors FOOTHILL RANCH, Calif., Sep 27, 2001 /PRNewswire via COMTEX/ -- CardioGenesis Corporation (Nasdaq: CGCP chart, msgs), a leading medical device company specializing in cardiac angiogenesis, today announced that Joseph R. Kletzel II, a senior executive with 25 years of operations and strategic management experience with leading biotech, pharmaceutical and medical device companies, has been appointed to its Board of Directors, effective immediately. Kletzel replaces Alan L. Kaganov, Sc.D., 62. Any comments on the above release? Could Cardiogenesis be the cardiac alliance for the revascularization heart patch? Any thoughts? Bruce Long

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next